Bristol-Myers Squibb Company (BMY) Operating cash flow 2016–2025
Bristol-Myers Squibb Company (BMY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$14.2BFY2025 · since FY2016: $3.1B → $14.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.2B | -6.8% |
| FY2024 | $15.2B | +9.6% |
| FY2023 | $13.9B | +6.1% |
| FY2022 | $13.1B | -19.4% |
| FY2021 | $16.2B | +15.3% |
| FY2020 | $14.1B | +71.2% |
| FY2019 | $8.2B | +16.2% |
| FY2018 | $7.1B | +34.0% |
| FY2017 | $5.3B | +72.5% |
| FY2016 | $3.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice